Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAPTIVATE India - A Cross-Sectional Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India.

NCT07121114 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07121114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07121114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAPTIVATE India - A Cross-Sectional Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India.
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
April 9, 2025
Completion date
July 9, 2025
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus